Complete Filing Data
Caring Brands, Inc. reported Net Income Loss of -$6.28 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Caring Brands, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Net Income Loss | -$6.3M | -$1.5M |
| Selling General And Administrative Expense | $147.7K | |
| Operating Income Loss | -$5.9M | |
| Interest Expense Nonoperating | $19.2K | |
| Revenues | $4.2K | |
| Gross Profit | $2.3K | |
| Cost Of Revenue | $1.9K | |
| Operating Expenses | $5.9M | |
| Nonoperating Income Expense | -$343.2K | |
| Other Nonoperating Income | $1.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|
| Net Income Loss | -$1.0M | -$862.8K | -$156.2K |
| Selling General And Administrative Expense | $999.9K | $26.5K | $156.1K |
| Operating Income Loss | -$999.5K | -$872.8K | -$156.1K |
| Interest Expense Nonoperating | $19.3K | -$10.0K | $67.00 |
| Revenues | $740.00 | $465.00 | |
| Gross Profit | $448.00 | -$1.6K | |
| Cost Of Revenue | $292.00 | $2.1K | |
| Operating Expenses | $871.2K | ||
| Nonoperating Income Expense | $10.0K | ||
| Other Nonoperating Income |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Stockholders Equity | $2.1M | $3.7M | -$265.8K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $2.2M | $469.0K | $18.2K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $1.7M | ||
| Retained Earnings Accumulated Deficit | -$7.1M | -$862.8K | |
| Other Accrued Liabilities Current | $6.5K | $16.7K | |
| Liabilities Current | $176.8K | $186.1K | |
| Liabilities And Stockholders Equity | $2.3M | $3.9M | |
| Liabilities | $235.5K | $186.1K | |
| Inventory Net | $12.8K | $13.7K | |
| Common Stock Value | $14.8K | $13.1K | |
| Cash And Cash Equivalents At Carrying Value | $2.2M | $469.0K | |
| Assets Current | $2.3M | $527.5K | |
| Assets | $2.3M | $3.9M | |
| Accounts Payable Current | $170.4K | $169.4K | |
| Subscription Receivable | -$800.00 | ||
| Stock Issued During Period Value Net Book Value Of Assets And Liabilities Acquired | |||
| Stock Issued During Period Value Common Stock To Be Issued | $43.8K | ||
| Long Term Debt Noncurrent | $58.7K | ||
| Common Stock Payable | $83.0K | ||
| Stock Issued During Period Values Net Book Value Of Assets And Liabilities Acquired | |||
| Stock Issued During Period Value Issuance Of Common Stock Upon Initial Public Offering Net Of Underwriting Discounts And Commissions And Other Issuance Costs | $3.2M | ||
| Settlement Of Related Party Debt | $79.0K | ||
| Repayments Of Related Party Debt | $120.0K | ||
| Loss On Sale Of Investments | $500.0K | ||
| Loans Payable Current |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|
| Stockholders Equity | $2.6M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $16.1K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $336.3K | $608.6K | |
| Retained Earnings Accumulated Deficit | -$3.1M | ||
| Other Accrued Liabilities Current | $93.3K | ||
| Liabilities Current | $570.2K | ||
| Liabilities And Stockholders Equity | $3.2M | ||
| Liabilities | $572.1K | ||
| Inventory Net | $12.9K | ||
| Common Stock Value | $13.7K | ||
| Cash And Cash Equivalents At Carrying Value | $16.1K | ||
| Assets Current | $46.0K | ||
| Assets | $3.2M | ||
| Accounts Payable Current | $347.5K | ||
| Subscription Receivable | -$1.6K | ||
| Stock Issued During Period Value Net Book Value Of Assets And Liabilities Acquired | $5.1M | $5.1M | |
| Stock Issued During Period Value Common Stock To Be Issued | |||
| Long Term Debt Noncurrent | $1.9K | ||
| Common Stock Payable | $43.8K | ||
| Stock Issued During Period Values Net Book Value Of Assets And Liabilities Acquired | -$862.8K | ||
| Stock Issued During Period Value Issuance Of Common Stock Upon Initial Public Offering Net Of Underwriting Discounts And Commissions And Other Issuance Costs | |||
| Settlement Of Related Party Debt | |||
| Repayments Of Related Party Debt | |||
| Loss On Sale Of Investments | |||
| Loans Payable Current | $129.4K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Net Cash Provided By Used In Operating Activities | -$1.7M |
| Increase Decrease In Accrued Liabilities | -$10.2K |
| Increase Decrease In Accounts Payable | -$95.1K |
| Increase Decrease In Prepaid Expenses Other | $80.0K |
| Net Cash Provided By Used In Financing Activities | $3.4M |
| Proceeds From Related Party Debt | $120.0K |
| Share Based Compensation | $1.2M |
| Proceeds From Issuance Of Other Long Term Debt | $170.0K |
| Proceeds From Issuance Of Common Stock | $6.8K |
| Proceeds From Issuance Initial Public Offering | $3.2M |
| Proceeds From Cash Acquired In Reverse Merger | |
| Net Cash Provided By Used In Investing Activities | |
| Increase Decrease In Inventories | -$882.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2024 | Q3 2024 |
|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$272.2K | -$15.00 |
| Increase Decrease In Accrued Liabilities | $30.5K | $21.6K |
| Increase Decrease In Accounts Payable | $1.4K | $402.00 |
| Increase Decrease In Prepaid Expenses Other | -$8.6K | |
| Net Cash Provided By Used In Financing Activities | ||
| Proceeds From Related Party Debt | ||
| Share Based Compensation | $400.0K | |
| Proceeds From Issuance Of Other Long Term Debt | ||
| Proceeds From Issuance Of Common Stock | ||
| Proceeds From Issuance Initial Public Offering | ||
| Proceeds From Cash Acquired In Reverse Merger | $608.6K | $608.6K |
| Net Cash Provided By Used In Investing Activities | $608.6K | $608.6K |
| Increase Decrease In Inventories |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 13.6M | |
| Weighted Average Number Of Diluted Shares Outstanding | 13.6M | |
| Earnings Per Share Diluted | $-0.46 | |
| Earnings Per Share Basic | $-0.46 | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 1.0M | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 14.8M | 13.1M |
| Common Stock Shares Issued | 14.8M | 13.1M |
| Common Stock Shares Authorized | 100.0M | 100.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 13.4M | 13.1M | 12.8M |
| Weighted Average Number Of Diluted Shares Outstanding | 13.4M | 13.1M | 12.8M |
| Earnings Per Share Diluted | $-0.08 | $-0.07 | $-0.03 |
| Earnings Per Share Basic | $-0.08 | $-0.07 | $-0.03 |
| Common Stock Par Or Stated Value Per Share | $0.00 | ||
| Preferred Stock Shares Outstanding | 0.00 | ||
| Preferred Stock Shares Issued | 0.00 | ||
| Preferred Stock Shares Authorized | 1.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | ||
| Common Stock Shares Outstanding | 13.7M | ||
| Common Stock Shares Issued | 13.7M | ||
| Common Stock Shares Authorized | 100.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Stock Issued During Period Value Issued For Services | $1.0M | |
| Stock Issued During Period Shares New Issues | 500.0K | |
| Prepaid Expense Current | $124.8K | $44.8K |
| Additional Paid In Capital | $9.1M | $4.5M |
| Professional And Contract Services Expense | $931.3K | |
| Payroll Expense | $2.0M | |
| Investment In Related Party Noncurrent | $500.0K | |
| Intellectual Property Related Party Noncurrent | $2.9M | |
| Stock Issued During Period Value New Issues | $6.8K | |
| Shares Sold On Subscription | 800.00 | |
| Issuance Of Stock And Warrants For Services Or Claims | ||
| Discounts On Convertible Promissory Notes | $118.0K | |
| Depreciation And Amortization | $300.0K | |
| Amortization Of License Agreement | ||
| Adjustments To Additional Paid In Capital Other | $83.0K | |
| Stock Issued During Period Value Restricted Stock Award Gross | $97.4K | |
| Stock Granted During Period Value Sharebased Compensation | $51.2K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Stock Issued During Period Value Issued For Services | $400.0K | $400.0K | ||
| Stock Issued During Period Shares New Issues | 2.1M | |||
| Prepaid Expense Current | $17.0K | |||
| Additional Paid In Capital | $5.6M | |||
| Professional And Contract Services Expense | $116.7K | |||
| Payroll Expense | $578.1K | |||
| Investment In Related Party Noncurrent | $500.0K | |||
| Intellectual Property Related Party Noncurrent | $2.6M | |||
| Stock Issued During Period Value New Issues | ||||
| Shares Sold On Subscription | ||||
| Issuance Of Stock And Warrants For Services Or Claims | $400.0K | |||
| Discounts On Convertible Promissory Notes | ||||
| Depreciation And Amortization | $150.0K | |||
| Amortization Of License Agreement | $6.8K | |||
| Adjustments To Additional Paid In Capital Other | ||||
| Stock Issued During Period Value Restricted Stock Award Gross | ||||
| Stock Granted During Period Value Sharebased Compensation |
Most recent annual filing with the SEC: March 31, 2026
Data sourced from SEC EDGAR public filings as of August 8, 2026.